These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29506598)

  • 1. Headache in Guillain-Barré Syndrome: Diagnostic and Management Implications.
    Alrohimi A; Jassal R
    Can J Neurol Sci; 2018 Mar; 45(2):240-242. PubMed ID: 29506598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Headache and Pain in Guillain-Barré Syndrome.
    Farmakidis C; Inan S; Milstein M; Herskovitz S
    Curr Pain Headache Rep; 2015 Aug; 19(8):40. PubMed ID: 26122532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome.
    Koichihara R; Hamano S; Yamashita S; Tanaka M
    Pediatr Neurol; 2008 Aug; 39(2):123-5. PubMed ID: 18639758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Headache and intracranial hypertension in Guillain-Barré syndrome: a case report and literature review.
    Wang T; Wang Z; Guo Z
    Int J Neurosci; 2019 Dec; 129(12):1179-1182. PubMed ID: 31317792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior reversible encephalopathy syndrome as a complication of Guillain-Barré syndrome.
    Bavikatte G; Gaber T; Eshiett MU
    J Clin Neurosci; 2010 Jul; 17(7):924-6. PubMed ID: 20409715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysautonomia in Guillain-Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes.
    Chakraborty T; Kramer CL; Wijdicks EFM; Rabinstein AA
    Neurocrit Care; 2020 Feb; 32(1):113-120. PubMed ID: 31297663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior reversible encephalopathy syndrome in Guillain-Barré syndrome.
    Chen A; Kim J; Henderson G; Berkowitz A
    J Clin Neurosci; 2015 May; 22(5):914-6. PubMed ID: 25800144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Posterior reversible encephalopathy syndrome during intravenous immunoglobulin therapy in Guillain-Barré syndrome].
    Watanabe E; Ido N; Saito T; Kato H; Terashi H; Aizawa H
    Rinsho Shinkeigaku; 2021 Jan; 61(1):12-17. PubMed ID: 33328417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior reversible encephalopathy in a GT1a positive oculopharyngeal variant of Guillain-Barré syndrome: A case-report and review of the literature.
    Xiromerisiou G; Kalampokini S; Rikos D; Provatas A; Tsouris Z; Markou K; Ralli S; Dardiotis E
    Clin Neurol Neurosurg; 2020 Sep; 196():106037. PubMed ID: 32623212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible cerebral vasoconstriction in Guillain-Barré syndrome.
    Wei DY; Kao J; Wu TY; Pereira JA; Anderson NE; Alan Barber P
    J Clin Neurosci; 2015 Jul; 22(7):1201-2. PubMed ID: 25778383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible cerebral vasoconstriction syndrome in Guillain-Barre syndrome: a case report and literature review.
    Seok HY; Eun MY; Kim S; Lee JJ; Oh GR; Kim GY; Sohn SI
    Neurol Sci; 2024 Jan; 45(1):101-107. PubMed ID: 37676373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior reversible encephalopathy syndrome as a revealing manifestation of Guillain-Barré syndrome.
    Etxeberria A; Lonneville S; Rutgers MP; Gille M
    Rev Neurol (Paris); 2012 Mar; 168(3):283-6. PubMed ID: 22318132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Headache and Papilledema in Guillain-Barré Syndrome.
    Alrohimi A; Ba F
    Can J Neurol Sci; 2018 May; 45(3):351-353. PubMed ID: 29374500
    [No Abstract]   [Full Text] [Related]  

  • 14. Guillain-Barré Syndrome Complicated by Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.
    Kobayashi H; Hoshina Y; Higa H; Watari T
    Eur J Case Rep Intern Med; 2023; 10(10):003949. PubMed ID: 37789979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior reversible encephalopathy syndrome associated with Guillain-Barré syndrome: Case report and clinical management considerations.
    Salvalaggio A; Cagnin A; Marson P; Ferracci F; Cortelli P; Corbetta M; Briani C
    J Clin Apher; 2020 Jun; 35(3):231-233. PubMed ID: 32289176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible cerebral vasoconstriction syndrome after intravenous immunoglobulin: a rare cause of headache and sudden onset weakness in a patient with Guillain-Barre syndrome.
    Soh RJH; Lim GZ; Vijayan J; Tan K
    BMJ Case Rep; 2024 Oct; 17(10):. PubMed ID: 39379303
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional recovery of untreated human immunodeficiency virus-associated Guillain-Barré syndrome: a case report.
    Schreiber AL; Norbury JW; De Sousa EA
    Ann Phys Rehabil Med; 2011 Nov; 54(8):519-24. PubMed ID: 22036304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior reversible encephalopathy as the initial manifestation of a Guillain-Barré syndrome.
    Sutter R; Mengiardi B; Lyrer P; Czaplinski A
    Neuromuscul Disord; 2009 Oct; 19(10):709-10. PubMed ID: 19616949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barre variant in the deployed setting.
    Chalela JA
    Mil Med; 2013 Oct; 178(10):e1156-8. PubMed ID: 24083932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed facial weakness in Guillain-Barré and Miller Fisher syndromes.
    Tatsumoto M; Misawa S; Kokubun N; Sekiguchi Y; Hirata K; Kuwabara S; Yuki N
    Muscle Nerve; 2015 Jun; 51(6):811-4. PubMed ID: 25287079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.